Edition:
United States

Carl Zeiss Meditec AG (AFXG.DE)

AFXG.DE on Xetra

42.40EUR
18 Aug 2017
Change (% chg)

€-0.09 (-0.22%)
Prev Close
€42.50
Open
€42.28
Day's High
€42.60
Day's Low
€42.01
Volume
72,886
Avg. Vol
108,243
52-wk High
€47.78
52-wk Low
€30.80

AFXG.DE

Chart for AFXG.DE

About

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and... (more)

Overall

Beta: 0.40
Market Cap(Mil.): €3,792.73
Shares Outstanding(Mil.): 89.44
Dividend: 0.42
Yield (%): 0.99

Financials

  AFXG.DE Industry Sector
P/E (TTM): 30.71 118.44 32.56
EPS (TTM): 1.38 -- --
ROI: 10.48 9.54 14.89
ROE: 11.27 14.77 16.13

Valeant in talks to sell eye-surgery assets to Carl Zeiss: Bloomberg

Canadian drugmaker Valeant Pharmaceuticals International Inc  is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG , Bloomberg reported.

Jun 06 2017

UPDATE 1-Valeant in talks to sell eye-surgery assets to Carl Zeiss - Bbg

June 6 Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG, Bloomberg reported.

Jun 06 2017

Valeant in talks to sell eye surgical products business - Bbg

June 6 Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG, Bloomberg reported.

Jun 06 2017

German stocks - Factors to watch on May 30

FRANKFURT, May 30 The DAX top-30 index looked set to open 0.1 percent lower on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0607 GMT.

May 30 2017

CORRECTED-BRIEF-Carl Zeiss Meditec H1 EBIT up 26 pct

* Adjusted EBIT margin increased to 15.2 percent (prior year: 14.3 percent)

May 10 2017

BRIEF-Carl Zeiss Meditec prelim H1 revenue up at EUR 588 mln

* Achieves first half 2016/17 revenue of approximately 580 million euros ($618.16 million)

Apr 04 2017

BRIEF-Carl Zeiss Meditec wins patent infringement action on trifocal intraocular lens

* Wins patent infringement action on trifocal intraocular lens against VSY Biotechnology and Fritz Ruck Ophthalmologische Systeme GmbH Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Mar 27 2017

Carl Zeiss Meditec plans share issue to raise 300 mln euros

FRANKFURT German medical technology company Carl Zeiss Meditec said it is to raise 300 million euros ($324 million) in a share issue to help finance acquisitions.

Mar 21 2017

Carl Zeiss Meditec plans share issue to raise 300 mln euros

FRANKFURT, March 21 German medical technology company Carl Zeiss Meditec said it is to raise 300 million euros ($324 million) in a share issue to help finance acquisitions.

Mar 21 2017

Earnings vs. Estimates